Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: A 12-month prospective study.

Conclusion: Dexamethasone implant should be considered as an effective and safe alternative in patients with BRVO and CRVO who have failed anti-VEGF therapy. Shortening the re-injection interval especially for CRVO cases should be considered. PMID: 31060385 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31060385?dopt=Abstract

Source: Cutaneous and Ocular Toxicology - May 5, 2019 Category: Toxicology Authors: Georgalas L, Tservakis I, Kiskira E, Petrou P, Papaconstantinou D, Kanakis M Tags: Cutan Ocul Toxicol Source Type: research